AbbVie Inc.
ABBV
186.06
USD+5.69
(+3.15%)Day's range
179.99
188.2543
52 wk Range
153.58
218.66
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 45,804,000,000 | 56,197,000,000 | 58,054,000,000 | 54,318,000,000 | 56,334,000,000 | |
| Gross Profit | 30,417,000,000 | 38,751,000,000 | 40,640,000,000 | 33,903,000,000 | 39,430,000,000 | |
| Operating Income | 11,363,000,000 | 17,924,000,000 | 18,117,000,000 | 12,757,000,000 | 9,137,000,000 | |
| Net Income | 4,616,000,000 | 11,542,000,000 | 11,836,000,000 | 4,863,000,000 | 4,278,000,000 | |
| Total Assets | 150,565,000,000 | 146,529,000,000 | 138,805,000,000 | 134,711,000,000 | 135,161,000,000 | |
| Total Current Liabilities | 28,661,000,000 | 35,194,000,000 | 29,538,000,000 | 37,841,000,000 | 38,749,000,000 | |
| Total Equity | 13,097,000,000 | 15,436,000,000 | 17,287,000,000 | 10,397,000,000 | 3,364,000,000 | |
| Free Cash Flow | 16,790,000,000 | 21,990,000,000 | 24,248,000,000 | 22,062,000,000 | 18,806,000,000 | |
| Cash from Operations | 17,588,000,000 | 22,777,000,000 | 24,943,000,000 | 22,839,000,000 | 18,806,000,000 | |
| Cash from Investing | -37,557,000,000 | -2,344,000,000 | -623,000,000 | -2,009,000,000 | -20,820,000,000 | |
| Cash from Financing | -11,501,000,000 | -19,039,000,000 | -24,803,000,000 | -17,222,000,000 | -5,211,000,000 | |
| Net Change in Cash | -31,475,000,000 | 1,297,000,000 | -545,000,000 | 3,613,000,000 | -7,290,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy